Oligodendrocyte-Specific Protein Peptides Induce Experimental Autoimmune Encephalomyelitis in SJL/J Mice

• Published in: The Journal of immunology (1950) Vol. 162; no. 12; pp. 7501 - 7509
• Main Authors: Stevens, David B, Chen, Kendall, Seitz, Robert S, Sercarz, Eli E, Bronstein, Jeff M
• Format: Journal Article
• Language: English
• Published: United States Am Assoc Immnol 15-06-1999
• Subjects: Amino Acid Sequence; Animals; Encephalomyelitis, Autoimmune, Experimental - etiology; Encephalomyelitis, Autoimmune, Experimental - immunology; Encephalomyelitis, Autoimmune, Experimental - pathology; Epitopes, T-Lymphocyte - immunology; Female; Lymphocyte Activation - drug effects; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Molecular Sequence Data; Nerve Tissue Proteins - administration & dosage; Nerve Tissue Proteins - immunology; Oligodendroglia - immunology; Peptide Fragments - administration & dosage; Peptide Fragments - chemistry; Peptide Fragments - immunology; Solubility; Species Specificity; T-Lymphocytes - immunology
• ISSN: 0022-1767; 1550-6606
• DOI: 10.4049/jimmunol.162.12.7501

Oligodendrocyte-specific protein (OSP) is a recently isolated and cloned, 207-aa, hydrophobic, four-transmembrane protein found in CNS myelin. It represents approximately 7% of total myelin protein. The OSP cDNA sequence has no significant homology with previously reported genes, but the predicted protein structure suggests that OSP is a CNS homologue of peripheral myelin protein-22. We previously reported the presence of anti-OSP Abs in the cerebrospinal fluid of relapsing-remitting multiple sclerosis (MS) patients, but not control patient groups. In this study, we tested the ability of a panel of 20-mer peptides with 10-aa overlaps, representing the sequence of murine OSP, to induce experimental autoimmune encephalomyelitis (EAE), an animal model for MS. SJL mice challenged with murine OSP peptides 52-71, 82-101, 102-121, 142-161, 182-201, and 192-207 exhibited clinical EAE. OSP:52-71 elicited severe relapsing-remitting EAE in some individuals. All other encephalitogenic peptides elicited, at most, a loss of tail tonicity from which the mice most often completely recovered. Mononuclear cell infiltrates and focal demyelination characteristic of EAE were evident. T cell proliferative responses were seen with all encephalitogenic peptides except 142-161 and 182-201. OSP peptides 72-91 and 132-151 did not cause clinical EAE, but did elicit robust proliferative responses. B10.PL and PL/J mice challenged with the same OSP peptide doses as SJL mice did not exhibit clinical EAE. These results in the SJL EAE model, together with the results from MS patient clinical samples, make OSP a promising candidate for autoantigenic involvement in MS.